These cells harbor typical TP53 mutations and exhibit persistent mTOR activation in the absence of PIK3CA mutations and PTEN genomic alterations that are more frequent in HPV-positive HNSCC lesions, thus reflecting the human HPV− HNSCC oncogenome (10). This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.